Identification of cellular MMP substrates using quantitative proteomics: isotope-coded affinity tags (ICAT) and isobaric tags for relative and absolute quantification (iTRAQ)
- PMID: 20135298
- DOI: 10.1007/978-1-60327-299-5_26
Identification of cellular MMP substrates using quantitative proteomics: isotope-coded affinity tags (ICAT) and isobaric tags for relative and absolute quantification (iTRAQ)
Abstract
Identification of protease substrates is essential to understand the functional consequences of normal proteolytic processing and dysregulated proteolysis in disease. Quantitative proteomics and mass spectrometry can be used to identify protease substrates in the cellular context. Here we describe the use of two protein labeling techniques, Isotope-Coded Affinity Tags (ICAT and Isobaric Tags for Relative and Absolute Quantification (iTRAQ), which we have used successfully to identify novel matrix metalloproteinase (MMP) substrates in cell culture systems (1-4). ICAT and iTRAQ can label proteins and protease cleavage products of secreted proteins, protein domains shed from the cell membrane or pericellular matrix of protease-transfected cells that have accumulated in conditioned medium, or cell surface proteins in membrane preparations; isotopically distinct labels are used for control cells. Tryptic digestion and tandem mass spectrometry of the generated fragments enable sequencing of differentially labeled but otherwise identical pooled peptides. The isotopic tag, which is unique for each label, identifies the peptides originating from each sample, for instance, protease-transfected or control cells, and comparison of the peak areas enables relative quantification of the peptide in each sample. Thus proteins present in altered amounts between protease-expressing and null cells are implicated as protease substrates and can be further validated as such.
Similar articles
-
Membrane protease degradomics: proteomic identification and quantification of cell surface protease substrates.Methods Mol Biol. 2009;528:159-76. doi: 10.1007/978-1-60327-310-7_12. Methods Mol Biol. 2009. PMID: 19153692
-
Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.Biol Chem. 2004 Jun;385(6):493-504. doi: 10.1515/BC.2004.058. Biol Chem. 2004. PMID: 15255181
-
Proteomic identification of cellular protease substrates using isobaric tags for relative and absolute quantification (iTRAQ).Curr Protoc Protein Sci. 2007 Aug;Chapter 21:21.18.1-21.18.12. doi: 10.1002/0471140864.ps2118s49. Curr Protoc Protein Sci. 2007. PMID: 18429318
-
Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer.Cancer Metastasis Rev. 2006 Mar;25(1):69-75. doi: 10.1007/s10555-006-7890-0. Cancer Metastasis Rev. 2006. PMID: 16680573 Review.
-
Amino acid-coded tagging approaches in quantitative proteomics.Expert Rev Proteomics. 2007 Feb;4(1):25-37. doi: 10.1586/14789450.4.1.25. Expert Rev Proteomics. 2007. PMID: 17288513 Review.
Cited by
-
Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities.Hum Genomics. 2015 Sep 23;9:24. doi: 10.1186/s40246-015-0046-y. Hum Genomics. 2015. PMID: 26395334 Free PMC article. Review.
-
Interplay between CCN1 and Wnt5a in endothelial cells and pericytes determines the angiogenic outcome in a model of ischemic retinopathy.Sci Rep. 2017 May 3;7(1):1405. doi: 10.1038/s41598-017-01585-8. Sci Rep. 2017. PMID: 28469167 Free PMC article.
-
CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway.Mol Carcinog. 2016 Nov;55(11):1688-1699. doi: 10.1002/mc.22419. Epub 2015 Oct 12. Mol Carcinog. 2016. PMID: 26457987 Free PMC article.
-
Proteases and Their Potential Role as Biomarkers and Drug Targets in Dry Eye Disease and Ocular Surface Dysfunction.Int J Mol Sci. 2022 Aug 29;23(17):9795. doi: 10.3390/ijms23179795. Int J Mol Sci. 2022. PMID: 36077189 Free PMC article. Review.
-
An emerging role of degrading proteinases in hypertension and the metabolic syndrome: autodigestion and receptor cleavage.Curr Hypertens Rep. 2012 Feb;14(1):88-96. doi: 10.1007/s11906-011-0240-9. Curr Hypertens Rep. 2012. PMID: 22081429 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources